244 Targeted therapy using intradermal injection of etanercept for remission induction in discoid lupus erythematosus (TARGET-DLE): results from a proof-of-concept phase II trial. (12th April 2019) - Yuzaiful, Md; Yusof, Md; Wittmann, Miriam; Fernandez, Catherine; Wilson, Duncan; Edward, Sara; Abignano, Giuseppina; Alase, Adewonuola; Sharples, Linda; Laws, Philip; Goodfield, Mark; Vital, Edward M; et al.